HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Merete Lund Hetland Selected Research
Merete Lund Hetland Research Topics
Disease
66
Rheumatoid Arthritis
01/2022 - 08/2004
13
Rheumatic Diseases (Rheumatism)
12/2021 - 02/2009
12
Psoriatic Arthritis
06/2022 - 11/2010
11
Axial Spondyloarthritis
11/2022 - 10/2015
10
Arthritis (Polyarthritis)
11/2022 - 04/2008
10
Necrosis
01/2020 - 02/2009
8
Inflammation (Inflammations)
03/2021 - 11/2007
8
Synovitis
01/2021 - 05/2006
7
Pain (Aches)
11/2022 - 08/2008
7
Fatigue
09/2017 - 08/2008
6
Ankylosing Spondylitis
01/2022 - 11/2010
5
Neoplasms (Cancer)
01/2019 - 02/2009
3
Infections
06/2022 - 03/2016
3
Joint Diseases (Joint Disease)
01/2020 - 02/2014
3
Body Weight (Weight, Body)
09/2017 - 05/2006
1
Spondylarthritis (Spinal Arthritis)
11/2022
1
Human Influenza (Influenza)
10/2022
1
Acute Coronary Syndrome
01/2022
1
Musculoskeletal Diseases (Musculoskeletal Disease)
12/2021
1
COVID-19
12/2021
1
Lymphoma (Lymphomas)
12/2017
1
Adrenal Insufficiency (Adrenal Gland Hypofunction)
10/2017
1
Overweight
04/2017
1
Obesity
04/2017
1
Melanoma (Melanoma, Malignant)
02/2017
1
Autoimmune Diseases (Autoimmune Disease)
01/2017
1
Osteitis
05/2015
1
Tenosynovitis
05/2015
1
Ovarian Neoplasms (Ovarian Cancer)
01/2013
Drug/Important Bio-Agent (IBA)
23
Biological Products
IBA
01/2022 - 09/2007
16
Antirheumatic Agents (DMARD)
IBA
11/2022 - 09/2009
13
Pharmaceutical Preparations
IBA
11/2022 - 01/2010
13
Tumor Necrosis Factor Inhibitors
IBA
11/2022 - 06/2010
11
Adalimumab (Humira)
FDA Link
06/2022 - 08/2006
11
Methotrexate (Mexate)
FDA Link
Generic
03/2021 - 05/2006
9
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
12/2018 - 09/2007
8
C-Reactive Protein
IBA
12/2020 - 11/2010
7
Etanercept (Enbrel)
FDA Link
01/2020 - 11/2007
7
Infliximab (Remicade)
FDA Link
01/2020 - 09/2007
6
Biosimilar Pharmaceuticals
IBA
11/2021 - 08/2017
6
Biomarkers (Surrogate Marker)
IBA
01/2021 - 01/2008
6
Rituximab (Mabthera)
FDA Link
01/2020 - 09/2011
6
ametantrone (HAQ)
IBA
12/2015 - 08/2008
5
Autoantibodies
IBA
01/2021 - 06/2010
5
Anti-Citrullinated Protein Antibodies
IBA
12/2020 - 04/2009
5
Abatacept (Orencia)
FDA Link
12/2020 - 07/2011
5
Rheumatoid Factor
IBA
12/2020 - 08/2011
4
tocilizumab (atlizumab)
FDA Link
01/2020 - 07/2011
3
secukinumab
IBA
06/2022 - 01/2020
3
Antibodies
IBA
12/2021 - 06/2010
3
Glucocorticoids
IBA
01/2020 - 08/2004
3
Prednisolone (Predate)
FDA Link
Generic
10/2017 - 11/2011
2
Prostaglandins A
IBA
11/2022 - 10/2015
2
ORALIT (ORS)
IBA
01/2022 - 01/2010
2
Lipids
IBA
03/2021 - 09/2017
2
Leflunomide (Arava)
FDA Link
Generic
01/2020 - 03/2012
2
CT-P13
IBA
01/2018 - 08/2017
2
Triamcinolone (Aristocort)
FDA Link
05/2015 - 04/2014
2
Betamethasone (Celestone)
FDA Link
06/2012 - 05/2006
2
Peptides (Polypeptides)
IBA
06/2012 - 06/2010
2
Steroids
IBA
02/2012 - 09/2009
2
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
09/2009 - 01/2008
1
COVID-19 Vaccines
IBA
10/2022
1
GP2017
IBA
11/2021
1
LDL Cholesterol
IBA
03/2021
1
Interferon Type I
IBA
01/2021
1
Interferon-alpha (Interferon Alfa)
IBA
01/2021
1
Adrenal Cortex Hormones (Corticosteroids)
IBA
12/2020
1
Leucovorin (Folinic Acid)
FDA Link
11/2020
1
Folic Acid (Vitamin M)
FDA Link
Generic
11/2020
1
baricitinib
IBA
01/2020
1
upadacitinib
IBA
01/2020
1
golimumab
FDA Link
01/2020
1
GLPG0634
IBA
01/2020
1
Janus Kinases
IBA
01/2020
1
Janus Kinase Inhibitors
IBA
01/2020
1
Certolizumab Pegol
FDA Link
01/2020
1
Ligands
IBA
01/2020
1
tofacitinib
IBA
01/2020
1
sarilumab
IBA
01/2020
1
Sulfasalazine (Azulfidine)
FDA Link
Generic
01/2020
1
amsonic acid (DAS)
IBA
01/2020
1
Acute-Phase Proteins (Acute-Phase Protein)
IBA
01/2018
1
Adrenocorticotropic Hormone (ACTH)
FDA Link
10/2017
1
Immunoglobulins (Immunoglobulin)
IBA
01/2017
1
Disintegrins
IBA
10/2016
1
interleukin-20 receptor
IBA
03/2016
1
Interferons
IBA
01/2015
1
Pattern Recognition Receptors
IBA
01/2015
1
Toll-Like Receptors (Toll-Like Receptor)
IBA
01/2015
1
Inflammasomes
IBA
01/2015
1
Guanosine Diphosphate (GDP)
IBA
11/2014
1
Indicators and Reagents (Reagents)
IBA
09/2014
1
Immunoglobulin M (IgM)
IBA
06/2012
Therapy/Procedure
20
Therapeutics
11/2022 - 08/2004
4
Biological Therapy
01/2019 - 09/2010
3
Injections
05/2015 - 08/2004
2
Drug Tapering
01/2021 - 01/2019
1
Drug Substitution
12/2014
1
Intra-Articular Injections
06/2012